openPR Logo
Press release

China Hydroxychloroquine Market is Projected to Grow at a CAGR Value of 4% During Forecast Period 2020-2030

06-14-2021 10:49 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

China Hydroxychloroquine Market

China Hydroxychloroquine Market

In the wake of the worsening coronavirus pandemic, hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19.

Browse Full Report - https://www.factmr.com/report/4769/hydroxychloroquine-market

As a result, the demand for hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons.

Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections. In 2020, from January to April, India has exported hydroxychloroquine API (active pharmaceutical ingredient) worth US$ 1.2 Bn. Attributed to above-mentioned facts global hydroxychloroquine market is estimated to experience a year on year growth of over 100% by the end of 2020.

Key Takeaways of Hydroxychloroquine Market Study

Due to skyrocketing demand for hydroxychloroquine, the global hydroxychloroquine market is expected to create a value opportunity of around US$ 2.3 Bn by the end of 2020.

The coronavirus pandemic has spiked the prices of API (active pharmaceutical ingredients) which is set to increase the market value by 2X through 2020.

To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=4769

Based on drug type, anti-rheumatic drug has dominated the consumption of hydroxychloroquine in 2018 and is poised to account for nearly half of the market share by 2030.

Due to the high prevalence of rheumatoid arthritis and systemic lupus erythematosus, United Stated is projected to remain a highly lucrative region during the forecast period.

In terms of production, currently, India accounted for nearly half of the global production in 2019.
“Increasing prevalence of rheumatoid arthritis and systemic lupus erythematosus across the globe is poised to amplify the hydroxychloroquine market growth during the forecast period. The COVID-19 crisis will give an uptick to sales”, says the Fact.MR analyst.

Capacity Expansions to Meet the Skyrocketing Demand for Hydroxychloroquine

The players of hydroxychloroquine include Abcam plc, Advanz Pharma, Amneal Pharmaceuticals Inc, Bayer AG, Dr Reddy's Lab, Ipca Laboratories Ltd., Laurus Labs and Mylan. In order to meet the increasing demand of hydroxychloroquine tablets, market goliaths have increased their production capabilities.

Companies like Amneal Pharmaceuticals Inc, Bayer AG, Dr Reddy's Lab, Ipca Laboratories Ltd, Zydus Cadila and Mylan have expanded their production capacities to meet the increasing the demand of hydroxychloroquine.

Market titans have also decided to ramp up their production capacities further if demand increases in the upcoming months. Companies like Zydus Cadila, Ipca laboratories ltd and Sino-Western Pharmaceutical are able to ramp their production capacities to over 500 tons per year. However, burgeoning demand has almost doubled the prices of hydroxychloroquine active pharmaceutical ingredients. This scenario is poised to continue till the pandemic abates.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4769

More Valuable Insights on Hydroxychloroquine Market:

Fact.MR, in its new offering, presents an unbiased analysis of the global hydroxychloroquine market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the Hydroxychloroquine market on the basis of drug type (anti-malarial drug, anti-rheumatic drug, lupus suppressant drug, anti COVID 19 drug and others) across six major regions.

The China Hydroxychloroquine Market research answers important questions, including the following:

1. Why China Hydroxychloroquine Market players are focusing on the business expansion in region?
2. Which regulatory authorities have granted approval to the application of China Hydroxychloroquine Market
3. What are the pros and cons of the China Hydroxychloroquine Market the environment?
4. Why players are targeting the production of segment?
5. What are the strategies implemented by emerging players in the global China Hydroxychloroquine Market?

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4769

The China Hydroxychloroquine Market report serves the readers with the following data:
• In-depth analysis of supply-side and demand-side trends.
• Direct and indirect impacts of the growth of relevant markets on the China Hydroxychloroquine Market.
• Importance of segment in various regions.
• Accurate Y-o-Y growth of the global China Hydroxychloroquine Market.
• Consumption trends among individuals across the globe.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4769/hydroxychloroquine-market
Content Source: https://www.factmr.com/media-release/1537/global-hydroxychloroquine-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Hydroxychloroquine Market is Projected to Grow at a CAGR Value of 4% During Forecast Period 2020-2030 here

News-ID: 2304427 • Views:

More Releases from Fact.MR

Military Exoskeleton Market is Projected to Increase at a CAGR of 14.5% Through 2033
Military Exoskeleton Market is Projected to Increase at a CAGR of 14.5% Through …
The global Military Exoskeleton Market (Mercado de exoesqueletos militares) reached a valuation of US$ 1.1 billion in 2023. Forecasts suggest a strong compound annual growth rate (CAGR) of 14.5% from 2023 to 2033 in exoskeleton sales. The market is witnessing increased adoption in the healthcare sector, alongside growing investments in advanced military exoskeleton technology, paving the way for significant opportunities for market players. Introduction of different types of soft actuators
Reusable Water Bottle Market to Reach US$ 14.53 Billion by 2034
Reusable Water Bottle Market to Reach US$ 14.53 Billion by 2034
The estimated size of the global reusable water bottle market (Margadh Buidéal Uisce Ath-inúsáidte) for 2024 stands at US$ 10.26 billion, with forecasts indicating a steady increase at a compound annual growth rate (CAGR) of 3.5%. By the end of 2034, this market is anticipated to reach US$ 14.53 billion. Market growth is being driven by increasing environmental concerns, busy lifestyles, and a rising awareness of the detrimental effects of
IP Telephony Market is Forecasted to Reach a Value of US$ 80.6 Billion by 2034
IP Telephony Market is Forecasted to Reach a Value of US$ 80.6 Billion by 2034
The global IP telephony market (IP 텔레포니 시장) is poised to achieve a valuation of US$ 37.3 billion in 2024, with projections indicating a subsequent expansion at a compound annual growth rate (CAGR) of 8%. This trajectory is expected to culminate in a robust market worth US$ 80.6 billion by the year 2034. Delving deeper into the realm of IP telephony unveils a trove of valuable insights. From the migration
Dermatological Products Market is Expected to reach USD 26,400 Million by 2032
Dermatological Products Market is Expected to reach USD 26,400 Million by 2032
The global dermatological products market (Margadh Táirgí Deirmeolaíochta) is approximated to be worth USD 15,500 million in 2022, with projections indicating a climb to USD 26,400 million by 2032. This growth trajectory entails a compound annual growth rate (CAGR) of 5.4% over the period spanning from 2022 to 2032. With a wide range of skin-related issues and disorders addressed, the dermatological products industry leads the healthcare and cosmetics sectors. Dermatological

All 5 Releases


More Releases for Hydroxychloroquine

Global Hydroxychloroquine Sulphate Market Size 2028 Trend & Forecast Report
An exceptional companion Hydroxychloroquine Sulphate Market report takes into consideration diverse segments of the market analysis that today's business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the Veterinary Diagnostics industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2022 whereas the historic year is 2019 which will tell
Increasing Burden of Malaria Providing Traction to Hydroxychloroquine Consumptio …
In the wake of the worsening coronavirus pandemic, hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a result, the demand for hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons. Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections.
Hydroxychloroquine Sulphate Market 2021 | Detailed Report
ReportsnReports publishes the report titled Hydroxychloroquine Sulphate that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Global Hydroxychloroquine Market Is Growing Rapidly as Sanofi and Teva Pharmaceu …
Hydroxychloroquine (Plaquenil and Hydrochloroquin) are commonly used in the treatment of osteoarthritis. Hydroxychloroquine and Hydroxyquinone (Dilantin) are considered "anti-inflammatory" medicines. They inhibit the action of prostaglandins and leukotrienes on the skin, joints, and tendons. It can reduce swelling and pain associated with arthritis. Hydroxychloroquine is in a category of drugs known as "dilators" which were first introduced to control and prevent arthritis from occurring. Hydroxychloroquine (Plaquenil), commonly referred to as
Hydroxychloroquine Sulfate Market Predicted to Accelerate the Growth by 2030
Hydroxychloroquine Sulfate: The Rescuer in COVID-19 Crisis Hydroxychloroquine (HCQ), is a drug used to forestall and treat jungle fever in zones where intestinal sickness stays touchy to chloroquine. Other utilizations incorporate treatment of rheumatoid joint pain, lupus, and porphyria cutanea tarda. Furthermore, hydroxychloroquine sulfate is the highly touted drug that’s taken for center stage due to its potential to treat patients with COVID-19. As result of this demand for hydroxychloroquine sulfate
Hydroxychloroquine Market Evaluation Targets Advancement Anticipated until 2030
n the wake of the worsening coronavirus pandemic, hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a result, the demand for hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons. Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections. Get